Accurate and reliable COVID-19 laboratory testing. In response to the current Coronavirus outbreak, Qnostics, a world-leading manufacturer of QC solutions for molecular infectious disease testing, has developed a SARS-CoV-2 control designed for use alongside molecular assays used in the testing of COVID-19. Accurate and reliable laboratory testing is an essential aspect of COVID-19 disease management and outbreak control. The use of a third-party quality control will allow diagnostic laboratories to effectively monitor the performance of diagnostic methods.
Whole pathogen and manufactured independently, our Qnostics Blood Borne Virus (BBV) Controls are designed to monitor the daily performance of molecular methods.
The target pathogens of primary concern are Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) – these pathogens are supplied in single packs and the concentration of each positive sample is designed to be within the dynamic range.
Monitor the daily performance of detection methods for key viruses. Whole pathogen and manufactured independently, the Respiratory Triplex Q Control is designed to monitor the daily performance of molecular methods used in the detection of Influenza A, Influenza B and Respiratory Syncytial Virus A (RSV A).
Five positive and five negative samples are conveniently supplied in a single pack reducing the number of individual kits required. The target concentration of each of the positive samples is designed to be within the dynamic range of most molecular assays.
